Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Bad
|
New words:
ADC, adenosine, Alector, amplification, atopic, auditor, bone, cGVHD, concept, consummation, creation, cytarabine, depatuxizumab, DMT, doubtful, EGFR, eleven, endpoint, exploratory, fewer, Fremont, GBM, GmbH, graft, host, IMMhance, intolerant, justify, Kabi, LDAC, lomustine, mafodotin, marrow, MAVIRET, MAVYRET, MURANO, negligence, neurodegenerative, Nutrition, OS, PARP, PCAOB, pibrentasvir, platinum, poly, polymerase, Postretirement, preliminarily, prolonged, pronouncement, proof, recurrent, revealed, Rituxan, Robert, Rubinstein, SLL, SONAR, temozolomide, TMZ, TNBC, topotecan, untaxed, upadacitinib, ustekinumab, vacated, wholly, WM
Removed:
Ablynx, affirmed, allocated, announcement, attaining, basic, Biogen, BMS, break, closing, comprised, concerted, declined, dedicate, distributed, duvelisib, elotuzumab, equitable, Euronext, exclusively, exit, favor, finite, footage, franchise, GlaxoSmithKline, headcount, healthcare, hematologic, Hillman, Hurwich, hypothetical, identifying, improper, inflow, Influenced, jointly, juror, lipid, methodology, Moody, mutually, myeloma, Nanobody, Neurocrine, neurodegeneration, NV, opted, outlook, partnering, Racketeer, rata, RBV, recently, recommended, remanded, repatriate, replaced, returned, reversed, Rochester, seasonal, shared, SICAD, square, Squibb, stable, supporting, suppurativa, terminate, ulcerative, undesignated, usage, withdrew
Filing tables
Filing exhibits
Related press release
Associated ABBV transcripts
ABBV similar filings
Filing view
External links
Exhibit 12.1
AbbVie Inc.
Ratio of Earnings to Fixed Charges
(unaudited)
The following table sets forth AbbVie’s historical ratios of earnings to fixed charges for the periods indicated. This information should be read in conjunction with the financial statements and accompanying notes included under Item 8, “Financial Statements and Supplementary Data” and Item 7, “Management's Discussion and Analysis of Financial Condition and Results of Operations.” For further information, see Exhibit 12.2 entitled “Computation of Ratio of Earnings to Fixed Charges”.
2017 | 2016 | 2015 | 2014 | 2013 | |||||||
Ratio of earnings to fixed charges | 7.3 | 7.4 | 8.0 | 6.0 | 16.6 |